OVEREVIEW: The Pandemic Is in Uncharted Territory

The United States set a new record for reported cases this week, breaking 500,000 for the first time in the pandemic as the third surge continued to build across nearly every state in the country.

Problem, Solution, SitRep, or ?: 

First, coronavirus infections increased. Then, hospitalizations. Now, deaths are on the rise.

Singapore firm invents coronavirus breathalyser with results in seconds

SINGAPORE (Reuters) - A company in Singapore has developed a breathalyser test for the new coronavirus which it says will enable people to know whether they are infected in under a minute.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

2nd study testing a COVID-19 antibody drug has a setback

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. coronavirus cases cross nine million: Some Governors resist additional steps --Reuters tally

(Reuters) - U.S. coronavirus cases crossed the 9 million mark on Friday, rising by 1 million in two weeks as the world’s worst-affected country faces a resurgence in the pandemic just ahead of elections.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Why Autopsies Are Proving Crucial During Covid-19

New CDC study shows how rapidly COV-10 can spread in a household

Slovakia to test all adults for SARS-CoV-2

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Remsdesvir: Some experts troubled about FDA approval for COVID-19 treatment

The United States reached a milestone, of sorts, when last week the Food and Drug Administration approved the first treatment for Covid-19.

The drug is called Veklury, although most people know it by its scientific name, remdesivir.

On Wednesday, its manufacturer, Gilead Sciences, said that remdesivir, which has been authorized for emergency use since the spring, had brought in $873 million in revenues so far this year and that it was the company’s second-best-selling drug in the third quarter, behind its H.I.V. drug, Biktarvy.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New research shows that Covid-19 antibodies can neutralize the virus and last up to five months

There’s encouraging news about antibodies in a new paper published in the journal Science from researchers at New York City’s Mount Sinai Hospital. In their study of the antibody responses of patients with either mild or moderate Covid-19, antibody levels appeared to stay relatively stable for at least five months, and their presence was correlated with the inactivation of the virus.

Antibodies are molecules pumped out by the immune system in response to infection, and they have a role in preventing future infections, though exactly how they function within the context of Covid-19 isn’t clear yet. Scientists are urgently trying to figure out whether the presence of antibodies actually means a person is protected from future infection as well as how long antibodies last in the body. Knowing this is crucial, especially for vaccine development.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

As pandemic raged and thousands died, USG regulators cleared most nursing homes of infection-control violations

Taiwan just went 200 days without a locally transmitted Covid-19 case. Here's how they did it

Europe Overview: facing new round of shutdowns amid virus surge

EU: WHO should have more power to investigate outbreaks

With election looming, U.S. faces record surge of coronavirus cases

Pages

Subscribe to Puerto Rico RSS
howdy folks
Page loaded in 1.187 seconds.